Revance Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $2.5M | 813k | 3.04 |
| 2024-09-30 | $6.0M | 1.2M | 5.19 |
| 2024-06-30 | $2.4M | 934k | 2.57 |
| 2024-03-31 | $2.7M | 543k | 4.92 |
| 2023-12-31 | $6.9M | 784k | 8.79 |
| 2023-09-30 | $13M | 1.1M | 11.47 |
| 2023-06-30 | $44M | 1.7M | 25.31 |
| 2023-03-31 | $35M | 1.1M | 32.21 |
| 2022-12-31 | $22M | 1.2M | 18.46 |
| 2022-06-30 | $12M | 829k | 13.82 |
| 2022-03-31 | $13M | 657k | 19.50 |
| 2021-12-31 | $13M | 806k | 16.32 |
| 2021-09-30 | $17M | 595k | 27.86 |
| 2021-03-31 | $13M | 448k | 27.95 |
| 2020-12-31 | $12M | 404k | 28.34 |
| 2020-09-30 | $11M | 453k | 25.14 |
| 2020-06-30 | $14M | 561k | 24.42 |
| 2019-12-31 | $1.8M | 108k | 16.23 |
| 2019-09-30 | $971k | 75k | 13.00 |
| 2019-06-30 | $696k | 54k | 12.96 |
| 2019-03-31 | $1.8M | 113k | 15.76 |
| 2018-12-31 | $794k | 40k | 20.12 |
| 2018-09-30 | $2.1M | 83k | 24.86 |
| 2018-06-30 | $3.7M | 136k | 27.44 |
| 2018-03-31 | $1.8M | 59k | 30.80 |
| 2017-12-31 | $949k | 27k | 35.75 |
| 2017-09-30 | $5.1M | 185k | 27.55 |
| 2017-06-30 | $4.7M | 180k | 26.40 |
| 2017-03-31 | $11M | 549k | 20.80 |
| 2016-12-31 | $8.4M | 407k | 20.71 |
| 2016-09-30 | $6.9M | 426k | 16.23 |
| 2016-06-30 | $5.8M | 425k | 13.58 |
| 2016-03-31 | $5.2M | 300k | 17.45 |
| 2015-12-31 | $11M | 316k | 34.15 |
| 2015-09-30 | $11M | 382k | 29.73 |
| 2015-06-30 | $9.9M | 310k | 31.98 |
| 2015-03-31 | $8.6M | 416k | 20.73 |
| 2014-12-31 | $6.8M | 403k | 16.94 |
| 2014-03-31 | $7.7M | 243k | 31.50 |